GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:9512515
| Citation |
Woo, M, Hakem, R, Soengas, MS, Duncan, GS, Shahinian, A, Kägi, D, Hakem, A, McCurrach, M, Khoo, W, Kaufman, SA, Senaldi, G, Howard, T, Lowe, SW and Mak, TW (1998) Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12:806-19 |
|---|---|
| Abstract |
Caspases are fundamental components of the mammalian apoptotic machinery, but the precise contribution of individual caspases is controversial. CPP32 (caspase 3) is a prototypical caspase that becomes activated during apoptosis. In this study, we took a comprehensive approach to examining the role of CPP32 in apoptosis using mice, embryonic stem (ES) cells, and mouse embryonic fibroblasts (MEFs) deficient for CPP32. CPP32(ex3-/-) mice have reduced viability and, consistent with an earlier report, display defective neuronal apoptosis and neurological defects. Inactivation of CPP32 dramatically reduces apoptosis in diverse settings, including activation-induced cell death (AICD) of peripheral T cells, as well as chemotherapy-induced apoptosis of oncogenically transformed CPP32(-/-) MEFs. As well, the requirement for CPP32 can be remarkably stimulus-dependent: In ES cells, CPP32 is necessary for efficient apoptosis following UV- but not gamma-irradiation. Conversely, the same stimulus can show a tissue-specific dependence on CPP32: Hence, TNFalpha treatment induces normal levels of apoptosis in CPP32 deficient thymocytes, but defective apoptosis in oncogenically transformed MEFs. Finally, in some settings, CPP32 is required for certain apoptotic events but not others: Select CPP32(ex3-/-) cell types undergoing cell death are incapable of chromatin condensation and DNA degradation, but display other hallmarks of apoptosis. Together, these results indicate that CPP32 is an essential component in apoptotic events that is remarkably system- and stimulus-dependent. Consequently, drugs that inhibit CPP32 may preferentially disrupt specific forms of cell death. |
| Links | |
| Keywords |
Animals; Antigens, CD3/pharmacology; Antigens, CD95/pharmacology; Apoptosis/drug effects; Apoptosis/genetics; Apoptosis/physiology; B-Lymphocytes/cytology; B-Lymphocytes/physiology; Bone Marrow Cells/cytology; Bone Marrow Cells/physiology; Caspase 3; Caspases; Cell Death/physiology; Cell Division/physiology; Cell Nucleus/metabolism; Cysteine Endopeptidases/deficiency; Cysteine Endopeptidases/genetics; Cysteine Endopeptidases/physiology; Cytotoxicity, Immunologic/genetics; Cytotoxicity, Immunologic/physiology; Embryo, Mammalian/cytology; Embryo, Mammalian/physiology; Embryonic and Fetal Development; Female; Gene Expression/genetics; Gene Expression/physiology; Longevity/genetics; Longevity/physiology; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Mutant Strains; Mutation/genetics; Mutation/physiology; Neutrophils/physiology; Osmotic Pressure; Stem Cells/radiation effects; T-Lymphocytes/cytology; T-Lymphocytes/drug effects; T-Lymphocytes/physiology; Tumor Cells, Cultured/cytology; Tumor Cells, Cultured/physiology; Tumor Cells, Cultured/radiation effects; Ultraviolet Rays |
| edit table |
Significance
Annotations
| Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| edit table |
See also
References
See Help:References for how to manage references in GONUTS.
